Phoenix Bio-Tech Corp Receives FDA Approval for TREP-SURE™ Syphilis Test

Phoenix Bio-Tech Corp. of Mississauga, ON announced that TREP-SURE™ has received U.S. Food and Drug Administration (FDA) approval. TREP-SURE™ EIA is a qualitative enzyme immunoassay for the in vitro diagnostic detection of Treponema pallidum (syphilis) antibodies in human serum or EDTA and citrated plasma.

The third generation of Syphilis testing, TREP-SURE™ offers unparalleled sensitivity and specificity, making it an excellent screening tool in the detection of Syphilis.

Contact Us | About Us